Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025
Carlsmed, Inc. (CARL)
Company Research
Source: GlobeNewswire
Fourth quarter 2025 revenue of ~$15.2 million, representing ~61% growth over Q4 2024Full Year 2025 revenue of ~$50.5 million; representing ~86% growth over 2024 CARLSBAD, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced preliminary and unaudited revenue for the fourth quarter and year ended December 31, 2025. Preliminary Q4 & FY 2025 Revenue Results Fourth quarter 2025 revenue was approximately $15.2 million, an approximate 61% increase compared to the fourth quarter 2024.Full year 2025 revenue was approximately $50.5 million, an approximate 86% increase compared to the full year 2024. “Our fourth quarter commercial performance capped a transformational year for Carlsmed and underscores the power of aprevo®. This platform technology provides surgeons with greater procedural predictability and has the potential to meaningf
Show less
Read more
Impact Snapshot
Event Time:
CARL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CARL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CARL alerts
High impacting Carlsmed, Inc. news events
Weekly update
A roundup of the hottest topics
CARL
News
- Carlsmed Reports Q4, FY 2025 revenue above estimate [Seeking Alpha]Seeking Alpha
- Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine JournalGlobeNewswire
- Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare ConferenceGlobeNewswire
- Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at BTIG Research.MarketBeat
CARL
Earnings
- 11/6/25 - Beat
CARL
Sec Filings
- 1/12/26 - Form 8-K
- 11/14/25 - Form SCHEDULE
- 11/6/25 - Form 10-Q
- CARL's page on the SEC website